1. Home
  2. TECX vs SWMR Comparison

TECX vs SWMR Comparison

Compare TECX & SWMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.82

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$42.03

Market Cap

618.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
SWMR
Founded
2019
2023
Country
United States
United States
Employees
60
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
618.9M
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
TECX
SWMR
Price
$30.82
$42.03
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$75.25
N/A
AVG Volume (30 Days)
167.5K
2.9M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$25.75
52 Week High
$35.99
$68.97

Technical Indicators

Market Signals
Indicator
TECX
SWMR
Relative Strength Index (RSI) 56.04 59.39
Support Level $17.71 N/A
Resistance Level $32.27 $68.97
Average True Range (ATR) 1.52 8.57
MACD -0.24 -0.27
Stochastic Oscillator 68.80 35.71

Price Performance

Historical Comparison
TECX
SWMR

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

Share on Social Networks: